Digestive Advantage Bc 30 Mega Study
Contents
Digestive Advantage Bc 30
Digestive Advantage Bc 30

Tags

Digestive Advantage Bc 30
Digestive Advantage Bc
Digestive Advantage Bc 30 (tablets)

Below is the degree of change seen after Digestive Advantage Bc 30 is higher than average.

Outcomes
of
Below is the change in the listed outcome after is higher than average.
Sort by Effect Size
Sort by Confidence
% Change from Baseline*
*
Change in the listed outcome after is higher than average.

Digestive Advantage Bc 30 Info

Property Value
Variable Name Digestive Advantage Bc 30 (tablets)
Aggregation Method SUM
Analysis Performed At 2020-10-09
Duration of Action 21 days
Filling Value 0
Kurtosis 6.0730519480519
Maximum Allowed Value 20 tablets
Mean 0.5625 tablets
Median 0 tablets
Minimum Allowed Value 0 tablets
Number of Aggregate Predictors 0
Number of Aggregate Outcomes 18
Number of Measurements 22
Number of Measurements (including those generated by tagged, joined, or child variables) 11
Public true
Onset Delay 30 minutes
Standard Deviation 0.33261416672783
Unit Tablets
User Variables 2
UPC 823019565441
Variable Category Treatments
Variable ID 859871
Variance 0.11063218390805